Literature DB >> 19155298

In-depth proteomics to define the cell surface and secretome of ovarian cancer cells and processes of protein shedding.

Vitor M Faça1, Samir M Hanash.   

Abstract

Current proteomics technologies allow substantial depth of analysis of cellular and subcellular proteomes as shown in the proteomic profiling of ovarian cancer cells. This in-depth analysis has elucidated the repertoire of proteins expressed on the cell surface and proteins released into the extracellular milieu, uncovering extensive shedding of extracellular domains of cell adhesion proteins and a highly dynamic protein secretion process. The protein sets identified provide a rich resource of potential circulating markers and targets for imaging and therapeutics for ovarian cancer.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19155298      PMCID: PMC4720963          DOI: 10.1158/0008-5472.CAN-08-3087

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  20 in total

Review 1.  Mining the plasma proteome for cancer biomarkers.

Authors:  Samir M Hanash; Sharon J Pitteri; Vitor M Faca
Journal:  Nature       Date:  2008-04-03       Impact factor: 49.962

2.  Increased expression of MUC18 correlates with the metastatic progression of mouse prostate adenocarcinoma in the TRAMP model.

Authors:  Guang-Jer Wu; Pingping Fu; Cheng-Feng Chiang; Wendy J Huss; Norman M Greenberg; Mei-Whey H Wu
Journal:  J Urol       Date:  2005-05       Impact factor: 7.450

3.  Global survey of organ and organelle protein expression in mouse: combined proteomic and transcriptomic profiling.

Authors:  Thomas Kislinger; Brian Cox; Anitha Kannan; Clement Chung; Pingzhao Hu; Alexandr Ignatchenko; Michelle S Scott; Anthony O Gramolini; Quaid Morris; Michael T Hallett; Janet Rossant; Timothy R Hughes; Brendan Frey; Andrew Emili
Journal:  Cell       Date:  2006-04-07       Impact factor: 41.582

4.  Loss of E-cadherin promotes ovarian cancer metastasis via alpha 5-integrin, which is a therapeutic target.

Authors:  Kenjiro Sawada; Anirban K Mitra; A Reza Radjabi; Vinay Bhaskar; Emily O Kistner; Maria Tretiakova; Sujatha Jagadeeswaran; Anthony Montag; Amy Becker; Hilary A Kenny; Marcus E Peter; Vanitha Ramakrishnan; S Diane Yamada; Ernst Lengyel
Journal:  Cancer Res       Date:  2008-04-01       Impact factor: 12.701

5.  A proteome resource of ovarian cancer ascites: integrated proteomic and bioinformatic analyses to identify putative biomarkers.

Authors:  Limor Gortzak-Uzan; Alex Ignatchenko; Andreas I Evangelou; Mahima Agochiya; Kevin A Brown; Peter St Onge; Inga Kireeva; Gerold Schmitt-Ulms; Theodore J Brown; Joan Murphy; Barry Rosen; Patricia Shaw; Igor Jurisica; Thomas Kislinger
Journal:  J Proteome Res       Date:  2007-12-13       Impact factor: 4.466

6.  Characterization of a human ovarian carcinoma cell line (NIH:OVCAR-3) with androgen and estrogen receptors.

Authors:  T C Hamilton; R C Young; W M McKoy; K R Grotzinger; J A Green; E W Chu; J Whang-Peng; A M Rogan; W R Green; R F Ozols
Journal:  Cancer Res       Date:  1983-11       Impact factor: 12.701

7.  The ALCAM shedding by the metalloprotease ADAM17/TACE is involved in motility of ovarian carcinoma cells.

Authors:  Ombretta Rosso; Tiziana Piazza; Italia Bongarzone; Armando Rossello; Delia Mezzanzanica; Silvana Canevari; Anna Maria Orengo; Andrea Puppo; Silvano Ferrini; Marina Fabbi
Journal:  Mol Cancer Res       Date:  2007-12       Impact factor: 5.852

Review 8.  Epithelial-mesenchymal interconversions in normal ovarian surface epithelium and ovarian carcinomas: an exception to the norm.

Authors:  Nuzhat Ahmed; Erik W Thompson; Michael A Quinn
Journal:  J Cell Physiol       Date:  2007-12       Impact factor: 6.384

9.  Glucocorticoids stabilize HER-2/neu messenger RNA in human epithelial ovarian carcinoma cells.

Authors:  B Y Karlan; J Jones; D J Slamon; L D Lagasse
Journal:  Gynecol Oncol       Date:  1994-04       Impact factor: 5.482

10.  Proteomic analysis of ovarian cancer cells reveals dynamic processes of protein secretion and shedding of extra-cellular domains.

Authors:  Vitor M Faça; Aviva P Ventura; Mathew P Fitzgibbon; Sandra R Pereira-Faça; Sharon J Pitteri; Ann E Green; Renee C Ireton; Qing Zhang; Hong Wang; Kathy C O'Briant; Charles W Drescher; Michèl Schummer; Martin W McIntosh; Beatrice S Knudsen; Samir M Hanash
Journal:  PLoS One       Date:  2008-06-18       Impact factor: 3.240

View more
  23 in total

Review 1.  Proteomics: a pragmatic perspective.

Authors:  Parag Mallick; Bernhard Kuster
Journal:  Nat Biotechnol       Date:  2010-07-09       Impact factor: 54.908

2.  Measuring the intra-individual variability of the plasma proteome in the chicken model of spontaneous ovarian adenocarcinoma.

Authors:  Adam M Hawkridge; Rebecca B Wysocky; James N Petitte; Kenneth E Anderson; Paul E Mozdziak; Oscar J Fletcher; Jonathan M Horowitz; David C Muddiman
Journal:  Anal Bioanal Chem       Date:  2010-07-17       Impact factor: 4.142

3.  Stress-induced phosphoprotein 1 as a secreted biomarker for human ovarian cancer promotes cancer cell proliferation.

Authors:  Tzu-Hao Wang; Angel Chao; Chia-Lung Tsai; Chih-Long Chang; Shun-Hua Chen; Yun-Shien Lee; Jen-Kun Chen; Yi-Jun Lin; Pi-Yueh Chang; Chin-Jung Wang; An-Shine Chao; Shuenn-Dyh Chang; Ting-Chang Chang; Chyong-Huey Lai; Hsin-Shih Wang
Journal:  Mol Cell Proteomics       Date:  2010-05-25       Impact factor: 5.911

4.  Progress in mining the human proteome for disease applications.

Authors:  Sam Hanash
Journal:  OMICS       Date:  2011-03

Review 5.  Advances in the proteomic investigation of the cell secretome.

Authors:  Kristy J Brown; Catherine A Formolo; Haeri Seol; Ramya L Marathi; Stephanie Duguez; Eunkyung An; Dinesh Pillai; Javad Nazarian; Brian R Rood; Yetrib Hathout
Journal:  Expert Rev Proteomics       Date:  2012-06       Impact factor: 3.940

Review 6.  Proteomic analysis of cerebrospinal fluid: toward the identification of biomarkers for gliomas.

Authors:  Fang Shen; Yang Zhang; Yu Yao; Wei Hua; Hai-Shi Zhang; Jing-Song Wu; Ping Zhong; Liang-Fu Zhou
Journal:  Neurosurg Rev       Date:  2014-05-01       Impact factor: 3.042

7.  Application of proteomics to cancer early detection.

Authors:  Samir Hanash; Ayumu Taguchi
Journal:  Cancer J       Date:  2011 Nov-Dec       Impact factor: 3.360

8.  Bottom-up proteomics analysis of the secretome of murine islets of Langerhans in elevated glucose levels.

Authors:  Andrew Schmudlach; Jeremy Felton; Robert T Kennedy; Norman J Dovichi
Journal:  Analyst       Date:  2017-01-16       Impact factor: 4.616

9.  Comparative proteomic analysis of plasma membrane proteins between human osteosarcoma and normal osteoblastic cell lines.

Authors:  Zhiyu Zhang; Lijun Zhang; Yingqi Hua; Xiaofang Jia; Jian Li; Shuo Hu; Xia Peng; Pengyuan Yang; Mengxiong Sun; Fang Ma; Zhengdong Cai
Journal:  BMC Cancer       Date:  2010-05-14       Impact factor: 4.430

10.  Potentially novel candidate biomarkers for head and neck squamous cell carcinoma identified using an integrated cell line-based discovery strategy.

Authors:  Lusia Sepiashvili; Angela Hui; Vladimir Ignatchenko; Willa Shi; Susie Su; Wei Xu; Shao Hui Huang; Brian O'Sullivan; John Waldron; Jonathan C Irish; Bayardo Perez-Ordonez; Fei-Fei Liu; Thomas Kislinger
Journal:  Mol Cell Proteomics       Date:  2012-08-23       Impact factor: 5.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.